1 hour ago
Eli Lilly (LLY) Stock Jumps 3% Following Strong Foundayo Clinical Data and Launch Metrics
Eli Lilly (LLY) stock climbs 3% after Foundayo's debut week prescriptions reach 1,390 and trial shows significant cardiovascular and mortality benefits.
The post Eli Lilly (LLY) Stock Jumps 3% Following Strong Foundayo Clinical Data and Launch Metrics appeared first on Blockonomi.
Source: Blockonomi →Related News
- 44 minutes ago
Beyond Meat (BYND) Stock Rockets 14% on Major New York Distribution Partnership
- 44 minutes ago
Critical Metals (CRML) Stock Soars 30% as Greenland Approves Tanbreez Ownership...
- 58 minutes ago
Intel (INTC) Stock Surges to Quarter-Century Peak Despite Analyst Skepticism
- 59 minutes ago
Marvell Technology (MRVL) Stock Soars 52% — Analyst Predicts $170 Target Ahead
- 1 hour ago
Morgan Stanley Flags PDD Holdings (PDD) Stock as Tactical Buy Following China Pe...